The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prognostic markers of radiographic progression in early rheumatoid arthritis
Abstract
Objective: To identify prognostic markers that are predictive of progressive erosive disease in patients with early rheumatoid arthritis (RA). Methods: The study involved an inception cohort of 111 consecutive patients with RA and a disease duration of <1 year. Patients were treated according to an algorithm designed to avoid overtreatment of mild disease and to accelerate treatment in patients who had continuous disease activity. Patients were evaluated for the presence of clinical and laboratory disease activity markers. We determined the frequency of CD4+,CD28 null T cells by flow cytometry, HLA–DRB1 gene polymorphisms by polymerase chain reaction (PCR)/sequencing, and 26 single‐nucleotide polymorphisms in 19 candidate genes by multiplex PCR and hybridization to an immobilized probe array. Data were analyzed using proportional odds models to identify prognostic markers predictive of erosive progression over 2 years on serial hand/wrist radiographs. Results: After 2 years, disease activity in 52% of the cohort was controlled by treatment with hydroxychloroquine and nonsteroidal agents. Forty‐eight percent of the patients did not develop erosions. Older age, presence of erosions at baseline, presence of rheumatoid factor, rheumatoid factor titer, and HLA–DRB1*04 alleles, particularly homozygosity for HLA–DRB1*04, were univariate predictors of radiographic progression. Promising novel markers were the frequency of CD4+,CD28 null T cells as an immunosenescence indicator, and a polymorphism in the uteroglobin gene. Conclusion: Clinical disease activity in patients with early RA can frequently be controlled with nonaggressive treatment, but this is not always sufficient to prevent new erosions. Rheumatoid factor titer, HLA–DRB1 polymorphisms, age, and immunosenescence markers are predictors of poor radiographic outcome. A polymorphism in the uteroglobin gene may identify patients who have a low risk of erosive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Self-citationGoronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., & Weyand, C. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12182-12187.2001 · Cited by 402
Self-citation
Cited by
Immunosenescence: molecular mechanisms and diseases
Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 960
Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., Saigo, K., Morinobu, A., Koshiba, M., Kuntz, K. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00008 · Cited by 873
Combe, B., Landewe, R., Lukas, C., Bolosiu, H. D., Breedveld, F., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044354 · Cited by 786
CD28− T cells: their role in the age-associated decline of immune function
Weng, N.-P., Akbar, A. N., & Goronzy, J. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.013 · Cited by 633
Self-citationClassification of osteoarthritis biomarkers: a proposed approach
Bauer, D. C., Hunter, D. J., Abramson, S. B., Attur, M., Corr, M., Felson, D., Heinegård, D., Jordan, J. M., Kepler, T. B., Lane, N. E., et al. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.001 · Cited by 405
The interplay between immunosenescence and age-related diseases
Barbé-Tuana, F., Funchal, G., Schmitz, C. R. R., Maurmann, R. M., & Bauer, M. E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00806-z · Cited by 384
Machold, K. P., Stamm, T. A., Nell, V. P. K., Pflugbeil, S., Aletaha, D., Steiner, G., Uffmann, M., & Smolen, J. S. (2006) · Rheumatology · doi:10.1093/rheumatology/kel237 · Cited by 301
Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?
de Rooy, D. P. C., van der Linden, M. P. M., Knevel, R., Huizinga, T. W. J., & van der Helm-van Mil, A. H. M. (2011) · Rheumatology · doi:10.1093/rheumatology/keq230 · Cited by 295
Goronzy, J. J., & Weyand, C. M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0970-0 · Cited by 292
“In early RA, frequencies of CD28 cells are prognostic predictors for the likelihood to develop erosive disease, supporting the notion that these cells are actively involved in the RA disease process [70].”
BackgroundSelf-citationThe Confluence of Sex Hormones and Aging on Immunity
Gubbels Bupp, M. R., Potluri, T., Fink, A. L., & Klein, S. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01269 · Cited by 277
Gilani, S. R., Vuga, L. J., Lindell, K. O., Gibson, K. F., Xue, J., Kaminski, N., Valentine, V. G., Lindsay, E. K., George, M. P., Steele, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008959 · Cited by 203
(2003) · doi:10.1186/ar974 · Cited by 156
Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells
Duftner, C., Dejaco, C., Hengster, P., Bijuklic, K., Joannidis, M., Margreiter, R., & Schirmer, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033939 · Cited by 23
Metadata
- Authors
- Goronzy, J. J., Matteson, E. L., Fulbright, J. W., Warrington, K. J., Chang‐Miller, A., Hunder, G. G., Mason, T. G., Nelson, A. M., Valente, R. M., Crowson, C. S., Erlich, H. A., Reynolds, R. L., Swee, R. G., O'Fallon, W. M., & Weyand, C. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 50
- Issue
- 1
- Pages
- 43-54
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1980455666
- Cited by
- 170
- References
- 2
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.